Stocks and Investing
Stocks and Investing
Wed, June 4, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, June 3, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, June 2, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, May 30, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, May 29, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Cory Kasimov Upgraded (BIIB) to Buy and Increased Target to $375 on, May 29th, 2014
Cory Kasimov of JP Morgan, Upgraded "Biogen Inc." (BIIB) to Buy and Increased Target from $300 to $375 on, May 29th, 2014.
Cory has made no other calls on BIIB in the last 4 months.
There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Cory's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Cory
- Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $415 on, Thursday, April 24th, 2014
- Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $395 on, Thursday, March 27th, 2014
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $400 on, Friday, February 14th, 2014
Contributing Sources